KEGG   PATHWAY: zca04934
Entry
zca04934                    Pathway                                
Name
Cushing syndrome - Zalophus californianus (California sea lion)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
zca04934  Cushing syndrome
zca04934

Organism
Zalophus californianus (California sea lion) [GN:zca]
Gene
113912234  CRH; corticoliberin [KO:K05256]
113908194  corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
113911766  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
113936968  neuroendocrine secretory protein 55 [KO:K04632]
113936966  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
113911474  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
113929853  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
113937275  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
113908984  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
113917313  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
113922228  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
113935770  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
113934371  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
113932237  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
113931821  PRKACB; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
113916866  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
113919503  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
113919173  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
113921771  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
113933699  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
113934022  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
113914325  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
113917002  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
113911293  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 isoform X1 [KO:K09048]
113911563  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
113926300  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
113915311  MEN1; menin isoform X1 [KO:K14970]
113924262  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
113932868  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
113934945  WDR5; WD repeat-containing protein 5 [KO:K14963]
113918957  WDR5B; WD repeat-containing protein 5B [KO:K14963]
113915195  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
113921953  KMT2D; histone-lysine N-methyltransferase 2D isoform X1 [KO:K09187] [EC:2.1.1.354]
113916997  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
113934560  CDKN2B; cyclin-dependent kinase 4 inhibitor B isoform X1 [KO:K04685]
113921783  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
113911106  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
113914083  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
113919651  RB1; retinoblastoma-associated protein isoform X1 [KO:K06618]
113938493  E2F1; transcription factor E2F1 [KO:K17454]
113912376  E2F2; transcription factor E2F2 [KO:K09389]
113927180  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
113939619  RASD1; dexamethasone-induced Ras-related protein 1 [KO:K07843]
113930637  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
113917448  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
113911420  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
113911345  AHR; aryl hydrocarbon receptor [KO:K09093]
113914363  AH receptor-interacting protein isoform X1 [KO:K17767]
113907993  AIPL1; aryl-hydrocarbon-interacting protein-like 1 [KO:K17767]
113915092  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
113922890  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
113936714  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
113930564  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
113927327  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
113921757  CACNA1C; LOW QUALITY PROTEIN: voltage-dependent L-type calcium channel subunit alpha-1C [KO:K04850]
113916795  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X2 [KO:K04851]
113931031  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
113932406  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
113929050  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
113925843  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
113911484  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
113921368  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
113928623  RAP1A; ras-related protein Rap-1A isoform X1 [KO:K04353]
113921540  RAP1B; ras-related protein Rap-1b [KO:K07836]
113911009  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
113908979  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
113917006  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
113933258  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
113912320  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
113922988  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
113911010  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
113909558  USP8; ubiquitin carboxyl-terminal hydrolase 8 [KO:K11839] [EC:3.4.19.12]
113938376  POMC; pro-opiomelanocortin [KO:K05228]
113912263  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
113918468  melanocortin-2 receptor accessory protein isoform X1 [KO:K22398]
113908705  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1 [KO:K18437] [EC:3.1.4.53]
113928691  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
113919857  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
113934034  NR5A1; steroidogenic factor 1 [KO:K08560]
113921297  SP1; transcription factor Sp1 [KO:K04684]
113932145  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
113911085  cytochrome P450 11B1, mitochondrial-like [KO:K00497] [EC:1.14.15.4]
118356903  cytochrome P450 11B1, mitochondrial-like isoform X1 [KO:K00497] [EC:1.14.15.4]
113923407  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
113924263  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
113916837  NCEH1; neutral cholesterol ester hydrolase 1 isoform X1 [KO:K14349] [EC:3.1.1.-]
113933639  ARMC5; armadillo repeat-containing protein 5 isoform X1 [KO:K22499]
113923905  AGT; angiotensinogen isoform X1 [KO:K09821]
113915804  AGTR1; type-1 angiotensin II receptor [KO:K04166]
113934691  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
113917830  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
113937245  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
113915286  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
113909205  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
113937989  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
113918169  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
113921922  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
113927035  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
113933656  KCNK2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
113939343  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
113933160  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H isoform X1 [KO:K04855]
113922869  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I [KO:K04856]
113912499  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
113915484  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
113937527  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
113917152  LDLR; low-density lipoprotein receptor [KO:K12473]
113912297  SCARB1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
113909555  cholesterol side-chain cleavage enzyme, mitochondrial isoform X1 [KO:K00498] [EC:1.14.15.6]
113909475  HSD3B2; 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 [KO:K00070] [EC:1.1.1.145 5.3.3.1]
113926301  steroid 21-hydroxylase isoform X1 [KO:K00513] [EC:1.14.14.16]
113932318  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
113921956  WNT1; proto-oncogene Wnt-1 [KO:K03209]
113923921  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
113911578  WNT2; protein Wnt-2 [KO:K00182]
113938914  WNT3A; protein Wnt-3a [KO:K00312]
113938999  WNT3; proto-oncogene Wnt-3 [KO:K00312]
113916433  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
113922486  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
113918500  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
113920632  WNT6; protein Wnt-6 [KO:K00445]
113917509  WNT7A; protein Wnt-7a [KO:K00572]
113922447  WNT7B; protein Wnt-7b [KO:K00572]
113922345  WNT8B; protein Wnt-8b [KO:K00714]
113928600  WNT8A; protein Wnt-8a [KO:K00714]
113907956  WNT9B; protein Wnt-9b [KO:K01064]
113938904  WNT9A; protein Wnt-9a [KO:K01064]
113921955  WNT10B; protein Wnt-10b [KO:K01357]
113920227  WNT10A; protein Wnt-10a [KO:K01357]
113914497  WNT11; protein Wnt-11 [KO:K01384]
113911953  WNT16; protein Wnt-16 [KO:K01558]
113911646  FZD1; frizzled-1 [KO:K02432]
113920600  FZD7; frizzled-7 [KO:K02432]
113939732  FZD2; frizzled-2 [KO:K02235]
113925060  FZD3; frizzled-3 [KO:K02329]
113913921  FZD4; frizzled-4 isoform X1 [KO:K02354]
113923054  FZD8; frizzled-8 [KO:K02375]
113919207  FZD5; frizzled-5 [KO:K02375]
113908652  FZD6; frizzled-6 isoform X1 [KO:K02376]
113913122  FZD10; frizzled-10 [KO:K02842]
113932963  FZD9; LOW QUALITY PROTEIN: frizzled-9 [KO:K02842]
113932759  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
113918049  DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
113939369  DVL2; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
113918509  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
113932986  AXIN1; axin-1 isoform X1 [KO:K02157]
113908035  AXIN2; axin-2 isoform X1 [KO:K04385]
113917714  CTNNB1; catenin beta-1 [KO:K02105]
113928748  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
113916148  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
113928407  TCF7; transcription factor 7 isoform X1 [KO:K02620]
113938298  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
113923025  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
113925268  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
zca00020  Citrate cycle (TCA cycle)
zca00140  Steroid hormone biosynthesis
zca04020  Calcium signaling pathway
zca04024  cAMP signaling pathway
zca04110  Cell cycle
zca04310  Wnt signaling pathway
zca04927  Cortisol synthesis and secretion
zca04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system